Nuformix (LSE:NFX) EBIT per Share : £-0.00 (TTM As of Sep. 2022)

View and export this data going back to 2015. Start your Free Trial

What is Nuformix EBIT per Share?

Nuformix's EBIT per Share for the six months ended in Sep. 2022 was £-0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2022 was £-0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Nuformix's EBIT per Share or its related term are showing as below:

LSE:NFX's 3-Year EBIT Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 3.6
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Nuformix's EBIT for the six months ended in Sep. 2022 was £-0.42 Mil.

Nuformix EBIT per Share Historical Data

The historical data trend for Nuformix's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix EBIT per Share Chart

Nuformix Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

EBIT per Share

Get a 7-Day Free Trial

-0.01

Nuformix Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23
EBIT per Share	Get a 7-Day Free Trial									-	-	-	-	-

Nuformix EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Nuformix's EBIT per Share for the fiscal year that ended in Mar. 2022 is calculated as

	EBIT per Share		(A: Mar. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-1.27	/	598.448
=	-0.00

Nuformix's EBIT per Share for the quarter that ended in Sep. 2022 is calculated as

	EBIT per Share		(Q: Sep. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.424	/	707.261
=	-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.00

Nuformix (LSE:NFX) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Nuformix EBIT per Share Related Terms

Thank you for viewing the detailed overview of Nuformix's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuformix (LSE:NFX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

1RT:Germany

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.nuformix.com

Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.